- Home
- CVU vs TCRX Comparison
CVU vs TCRX Comparison
Compare CVU & TCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVU
- TCRX
- Stock Information
- Founded
- CVU 1980
- TCRX 2018
- Country
- CVU United States
- TCRX United States
- Employees
- CVU N/A
- TCRX N/A
- Industry
- CVU Military/Government/Technical
- TCRX Biotechnology: Pharmaceutical Preparations
- Sector
- CVU Industrials
- TCRX Health Care
- Exchange
- CVU Nasdaq
- TCRX Nasdaq
- Market Cap
- CVU 70.2M
- TCRX 67.9M
- IPO Year
- CVU N/A
- TCRX 2021
- Fundamental
- Price
- CVU $3.40
- TCRX $1.44
- Analyst Decision
- CVU
- TCRX Strong Buy
- Analyst Count
- CVU 0
- TCRX 6
- Target Price
- CVU N/A
- TCRX $9.83
- AVG Volume (30 Days)
- CVU 37.4K
- TCRX 520.8K
- Earning Date
- CVU 05-14-2025
- TCRX 05-12-2025
- Dividend Yield
- CVU N/A
- TCRX N/A
- EPS Growth
- CVU N/A
- TCRX N/A
- EPS
- CVU 0.26
- TCRX N/A
- Revenue
- CVU $81,078,864.00
- TCRX $2,816,000.00
- Revenue This Year
- CVU N/A
- TCRX $47.30
- Revenue Next Year
- CVU N/A
- TCRX $74.30
- P/E Ratio
- CVU $13.08
- TCRX N/A
- Revenue Growth
- CVU N/A
- TCRX N/A
- 52 Week Low
- CVU $2.16
- TCRX $1.02
- 52 Week High
- CVU $5.85
- TCRX $9.69
- Technical
- Relative Strength Index (RSI)
- CVU 45.19
- TCRX 49.74
- Support Level
- CVU $3.26
- TCRX $1.02
- Resistance Level
- CVU $3.56
- TCRX $1.36
- Average True Range (ATR)
- CVU 0.24
- TCRX 0.16
- MACD
- CVU 0.03
- TCRX 0.05
- Stochastic Oscillator
- CVU 62.50
- TCRX 77.78
About CVU CPI Aerostructures Inc.
CPI Aerostructures Inc is engaged in the manufacturing of structural aircraft parts for fixed-wing aircraft and helicopters in both the commercial and defense markets in the United States. It also provides engineering, program management, supply chain management and kitting, and Maintenance Repair and Overhaul (MRO) services. CPI also acts as a subcontractor to prime aircraft manufacturers in the production of commercial aircraft parts. CPI Aero supplies the E-2D Advanced Hawkeye surveillance aircraft, the A-10 Thunderbolt attack jet, the Gulfstream G650, the UH-60 BLACK HAWK helicopter, and the S-92 helicopter and others.
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.